- Previous Close
92.12 - Open
91.50 - Bid --
- Ask --
- Day's Range
90.64 - 91.94 - 52 Week Range
89.56 - 124.85 - Volume
97,351 - Avg. Volume
485,032 - Market Cap (intraday)
24.186B - Beta (5Y Monthly) --
- PE Ratio (TTM)
96.60 - EPS (TTM)
0.94 - Earnings Date Feb 13, 2025
- Forward Dividend & Yield 2.50 (2.71%)
- Ex-Dividend Date May 8, 2025
- 1y Target Est
126.82
DSM-Firmenich AG engages in the provision of solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Animal Nutrition & Health segment offers animal proteins, as well as vitamins, performance solutions, and data-driven precision service. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, active pharmaceutical ingredients, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise services, and customized solutions. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
www.dsm-firmenich.com26,301
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DSFIR.AS
View MorePerformance Overview: DSFIR.AS
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is AEX-Index (^AEX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DSFIR.AS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DSFIR.AS
View MoreValuation Measures
Market Cap
24.44B
Enterprise Value
27.00B
Trailing P/E
98.00
Forward P/E
18.73
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.90
Price/Book (mrq)
1.09
Enterprise Value/Revenue
2.11
Enterprise Value/EBITDA
15.09
Financial Highlights
Profitability and Income Statement
Profit Margin
1.95%
Return on Assets (ttm)
0.93%
Return on Equity (ttm)
1.22%
Revenue (ttm)
12.8B
Net Income Avi to Common (ttm)
250M
Diluted EPS (ttm)
0.94
Balance Sheet and Cash Flow
Total Cash (mrq)
2.72B
Total Debt/Equity (mrq)
23.26%
Levered Free Cash Flow (ttm)
596.88M